Small Molecule Drug Product CDMOs

Vetter Pharma

Germany

Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.

ResolveMass Laboratories Inc. is a Canadian pharmaceutical CRO and CDMO providing analytical testing, characterization, and drug development support for pharmaceutical, biotechnology, and medical device companies worldwide. Our expertise spans small molecules, peptides, biologics, biosimilars, oligonucleotides, polymers, and complex drug products. We offer specialized services including mass spectrometry (LC-MS/MS, LC-HRMS), peptide characterization, impurity identification, nitrosamine analysis, extractables and leachables (E&L) studies, bioanalytical testing, stability studies, method development, and regulatory support. Our multidisciplinary scientific team helps clients address complex analytical challenges and generate high-quality data to support research, development, manufacturing, and regulatory submissions. ResolveMass Laboratories operates from Canada and serves clients across North America, Europe, and Asia. The company maintains an ISO 9001:2015 certified Quality Management System, is FDA-registered, and holds a Health Canada Drug Establishment Licence for GMP-compliant operations. We are committed to delivering scientifically rigorous, reliable, and timely solutions that accelerate drug development and support regulatory success.

Aarti Pharmalabs Limited

India

Aarti Pharmalabs Limited is a leading Indian small-molecule CDMO specializing in API and drug substance development and manufacturing. They operate six manufacturing plants with two R&D centers, accredited by USFDA, EU GMP, EDQM, and KFDA. They provide services from process R&D through stability studies, scale-up, process validation, and commercial manufacturing, including high-potent/cytotoxic molecules and flow chemistry.

AbbVie Contract Manufacturing (AbbVie CMO)

Italy

AbbVie Contract Manufacturing is an embedded CMO within AbbVie, providing third-party contract manufacturing services for over 40 years across 12 locations in the US and Europe. They offer services spanning antibody drug conjugates, aseptic fill/finish, biologics (mAbs and derivatives), custom API, eye care, hot melt extrusion, HPAPI, and oral solid dose manufacturing.

Abiogen Pharma S.p.A.

Italy

Abiogen Pharma S.p.A. is an Italian pharmaceutical company established in 1997 with a century-long heritage, performing CMO and CDMO activities alongside its own product portfolio. They offer formulation development, analytical testing, scale-up, and commercial production from their cutting-edge manufacturing plant in Pisa. They specialize in bone metabolism, hypovitaminosis D, pain, dermatology, respiratory, and gastroenterology.

ACIC Pharmaceuticals Inc

Canada

ACIC Pharmaceuticals Inc is a CDMO headquartered in Coral Springs, Florida, providing integrated pharmaceutical solutions from molecule to market. They offer API manufacturing, CDMO services for complex injectables including long-acting and cytotoxic injectables, regulatory support, and pharmaceutical equipment solutions. They have 249 FDA-approved products across a wide range of dosage forms.

Acino International AG

Switzerland

Acino International AG is a Swiss pharmaceutical company headquartered in Zurich, operating as a CDMO specializing in oral solid dosage forms. With over 50 years of manufacturing experience, they operate facilities in five countries with annual capacity of billions of tablets and millions of capsules. They specialize in advanced drug delivery systems including multi-unit pellet systems (MUPS), minitablets, and complex modified-release formulations.

ACS DOBFAR S.p.A.

Italy

ACS DOBFAR S.p.A. is an Italian pharmaceutical company established in 1973, specializing in anti-infective APIs (Cephalosporins, Carbapenems, Penicillins) and finished dosage forms. With 23 production facilities across four continents and over 3,000 employees, they operate as both an API manufacturer and a CMO for multinational pharmaceutical companies. They are approved by AIFA, FDA, ANVISA, and Health Canada.

Adamed Pharma S.A.

Poland

Adamed Pharma S.A. is a European pharmaceutical and biotechnology company headquartered in Poland, established in 1986. They manufacture approximately 94 million units of medicine packs annually across 19 therapeutic areas, with products available in dozens of markets. They hold GMP and GDP API certifications, and operate as both a manufacturer of their own products and a licensee, with 256 pharmaceutical patents and approximately 900 SKUs.

Addii Biotech Pvt Ltd

India

Addii Biotech Pvt Ltd is an Indian pharmaceutical company established in 2010, initially as a marketing company that expanded into manufacturing in 2017. They manufacture tablets, capsules, ointments, dry syrups, and other preparations at their WHO-GMP certified facility in Baddi, Himachal Pradesh. They hold ISO 9001:2015, WHO-GMP, and FDA-Ghana certifications and supply to government institutions and hospitals.

Adelco SA

Greece

Adelco S.A. is one of the oldest pharmaceutical and cosmetics manufacturers in Greece, established in 1934. They operate as both a CMO/CDMO and a branded pharmaceutical and cosmetics manufacturer. Their EU-GMP certified production facility manufactures a range of pharmaceutical products including tablets, capsules, liquids, creams, and ointments. They are an independent manufacturer extending activities beyond Greek national borders.

Afric Phar

Morocco

Afric-Phar is a Moroccan pharmaceutical company offering contract manufacturing services with a complete value chain including regulatory affairs, quality assurance, quality control, production, logistics, and promotion. The company operates from a 1,300 m2 industrial site and provides global contract services for pharmaceutical partners entering the North African market.

Aggrega Pharma, LLC

France

Aggrega Pharma LLC is a U.S.-based pharmaceutical company created in 2019 by four European-based pharmaceutical companies (Bluepharma, Rafarm, Substipharm, Welding) focused on developing, manufacturing, and marketing generic drug products. The company leverages its shareholders' development and commercial manufacturing facilities, including FDA-inspected sites in Portugal and Greece, with capabilities in oral solids, sterile injectables, and complex ophthalmics.

Agno Pharmaceuticals

United States

Agno Pharmaceuticals is a U.S.-headquartered global end-to-end CDMO providing comprehensive solutions from API development and intermediates through complex drug product formulation to cGMP manufacturing for both clinical trials and commercial production. The company supports both innovative and generic pharmaceutical sectors with capabilities in small molecule APIs, highly potent APIs (HPAPIs), sterile APIs, and drug products.

Aizant Drug Research Solutions

India

Aizant Drug Research Solutions Pvt. Ltd., founded in 2008, is a trusted global CDMO offering comprehensive API and Formulation R&D, CDMO, CMO, and CRO services across multiple therapeutic areas and dosage forms. The company operates USFDA and EU-accredited facilities with capabilities in hot melt extrusion, spray drying, and complex generics, providing end-to-end pharmaceutical development and manufacturing solutions.

Ajinomoto Bio-Pharma Services

Belgium

Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) is a fully integrated global CDMO providing comprehensive development and cGMP manufacturing services for both small and large molecule pharmaceuticals. With facilities in Belgium, the United States, Japan, and India, the company offers platform technologies including oligonucleotide manufacturing, ADC conjugation, small molecule API synthesis, and aseptic fill-finish services. The Althea fill-finish site was acquired by PCI Pharma Services.

Akriti Pharmaceuticals Pvt. Ltd.

India

Akriti Pharmaceuticals Pvt. Ltd. is an Indian pharmaceutical manufacturer with EU GMP and TGA approved manufacturing facilities. The company delivers affordable quality medicines across the world with efficient manufacturing services backed by a qualified technical team, operating as a contract manufacturer for global healthcare partners.

Akums Drugs & Pharmaceuticals Ltd

India

Akums Drugs & Pharmaceuticals Ltd. is India's largest CDMO with 30% domestic market share, operating 15+ state-of-the-art manufacturing facilities with over 4,100 commercialized formulations across 60+ dosage forms. The company serves 1,500+ pharmaceutical companies and provides end-to-end services including API manufacturing (737 MT annual capacity across 3 facilities), formulation development, clinical trial materials, and commercial-scale production of tablets, capsules, injectables, soft gels, syrups, topicals, and nutraceuticals.

Almac Group

Ireland

Almac Group is a major global CDMO with 55+ years of experience, 7,800+ employees, and 18 facilities worldwide. The company provides end-to-end pharmaceutical services including API manufacture, formulation development, clinical trial supplies, commercial-scale manufacturing, packaging, serialization, and distribution, with additional capabilities in precision medicine diagnostics and drug discovery. Almac has contributed to approximately 50% of approved NMEs in the last 6 years.

Alpex Pharma SA

Switzerland

Alpex Pharma is a Swiss research-based pharmaceutical company and CDMO with 37+ years of experience, offering end-to-end drug development from API to finished pharmaceutical product. The company specializes in oral dissolving tablets (ODTs) with 100+ patents and has commercialized 150+ products with 200+ million units sold annually. Facilities are FDA, Swissmedic, EU-GMP, and BRC-FOOD approved.

Antibiotice S.A.

Romania

Antibiotice S.A. is a Romanian pharmaceutical company with over 70 years of experience, specializing in the manufacturing of antibiotics (injectable and oral), APIs, and nystatin. They hold FDA approval for injectable ampicillin, nafcillin, and nystatin API, and operate eight GMP-certified manufacturing lines. They provide contract manufacturing services for APIs and finished products.

API Co., Ltd. (Japan)

Japan

API Co., Ltd. is a Japanese pharmaceutical company specializing in contract manufacturing (CMO/CDMO) of antibiotics (vials, lyophilized products), APIs (including heparinoid), and biotech products. Their Ikeda Pharmaceutical Plant handles antibiotic formulation, lyophilization, powder filling, and packaging under GMP conditions.

APL (Apotek Produktion & Laboratorier AB)

Sweden

APL (Apotek Produktion & Laboratorier AB) is a Swedish state-owned pharmaceutical company and one of Europe's leading companies in development, analysis, and manufacturing of extemporaneous and stock preparations. They also operate as an established CDMO for the life science industry, offering formulation development, analytical method development, stability studies, and sterile manufacturing. They have invested in 3D printing technology for automated drug dispensing.

Apotex (incl. Apotex Pharmachem)

Canada

Apotex is Canada's largest pharmaceutical company with global operations spanning API manufacturing, finished dosage form production, and CDMO/co-development services. With capacity to produce approximately 25 billion finished doses annually and three API manufacturing sites, they serve both their own generic portfolio and external partners through Apotex Pharmachem (API CDMO) and Apotex Fermentation (fermentation-based manufacturing).

Aprecia Pharmaceuticals

United States

Aprecia Pharmaceuticals is a Cincinnati-based CDMO that pioneered the use of 3D printing (binder jet 3DP) technology for pharmaceutical manufacturing. Their proprietary ZipDose technology platform produces rapidly disintegrating oral solid dosage forms. They hold FDA-registered facilities with operations spanning analysis, API manufacture, labeling, manufacturing, and packaging. They have FDA-approved products including tablets and oral suspensions.

AqVida GmbH

Germany

AqVida GmbH is a German CDMO specializing in sterile oncology injectable products. Based in northern Germany, they manufacture cancer medicines using a state-of-the-art robotic filling line designed for aseptic production of cytostatics for parenteral use. Their facility features OEB5 containment with isolator technology for handling toxic parenteralia, with vial sizes from 2 to 100ml and batch sizes of 5 to 300 liters. They also provide GMP consulting services.

Aragen Life Sciences Ltd.

India

Aragen Life Sciences Ltd. (formerly GVK Biosciences) is a CRDMO (Contract Research, Development, and Manufacturing Organization) headquartered in Hyderabad, India, with over 4,000 scientists. They provide integrated services spanning small molecules and large molecules (biologics) from discovery through commercialization. Their capabilities include HPAPI handling (cytotoxics, immunosuppressants, ADC toxins), particle science, process validation, and IND enabling services across multiple FDA-registered facilities.

Ardena

Belgium

Ardena is a Belgian-headquartered global specialist CDMO and CRO focused on precision medicine development of complex and innovative molecules, with a leading position in nanomedicine development. They offer integrated services spanning drug substance manufacturing, drug product manufacturing (oral solids, injectables, nanomedicines), bioanalytical testing, and CMC regulatory support. Their multi-site network includes capabilities for HPAPI manufacturing, spray drying, hot melt extrusion, and aseptic sterile manufacturing.

Ascendia Pharmaceutical Solution

United States

Ascendia Pharmaceutical Solutions is a CDMO specializing in formulation development and cGMP manufacturing of drug products. Known for novel enabling technologies such as NanoSol (nanoparticle), AmorSol (amorphous solid dispersion), EmulSol (nano-emulsion), and LipidSol (lipid nanoparticle), they help partners advance poorly soluble compounds from pre-formulation through commercialization.

Asymchem

China

Asymchem is a leading CDMO with 25+ years of experience, 9,700+ employees, and eight R&D and manufacturing sites. They specialize in complex chemistry for small molecule APIs, including peptide synthesis, and provide comprehensive CMC services from R&D through commercial production. They have 65+ successful regulatory inspections (FDA, NMPA, TGA, MFDS) and 1,100+ active clients with 600+ clinical and 40+ commercial projects.

Aurigene Services

India

Aurigene Pharmaceutical Services (formerly Aurigene Services) is a leading global CRDMO with 25+ years of experience, offering integrated CRO (discovery) and CDMO services for both small and large molecules. The company provides end-to-end drug development solutions from target identification through commercial manufacturing, operating 16 USFDA-approved sites. Aurigene has 700+ scientists, 400+ completed projects, and 18 successfully commercialized NCEs. Their small molecule CDMO capabilities span drug substance development and manufacturing, formulations, and specialty areas including peptides, high potent APIs, mPEGs, steroids, carbohydrates, and flow chemistry. Their biologics division offers process development and clinical scale manufacturing for monoclonal antibodies, bispecific antibodies, and proteins, with a new biomanufacturing facility in Hyderabad.

Aurobindo Pharma (incl. Eugia/Generis)

India

Aurobindo Pharma Limited is one of the world's largest vertically integrated generic pharmaceutical companies, headquartered in Hyderabad, India, operating 29 manufacturing facilities globally with capacity to produce 50+ billion formulation units and 19,000+ MT of APIs annually. Through subsidiaries Eugia Pharma Specialities (sterile injectables, oncology), CuraTeQ Biologics (biosimilars), and TheraNym Biologics, Aurobindo operates as a major CDMO. The company holds 830 US ANDA filings with 600+ approvals, and has manufacturing and packaging facilities across India, the US, Portugal, Brazil, and China. CuraTeQ received EMA GMP certification in 2024 for mammalian and microbial drug substance production, prefilled syringe and vial filling. Aurobindo's CDMO expansion includes a contract with MSD for biologics manufacturing with 15,000L bioreactors and 25-30 million vial annual capacity.

Beijing Sunho Pharmaceutical Co., Ltd

China

Beijing Sunho Pharmaceutical Co., Ltd is a Chinese pharmaceutical company manufacturing oral dosage forms. They have FDA-approved capsule products, are FDA-registered, and have passed FDA inspection with NAI status. They produce products including Tranexamic Acid Injection, Aripiprazole freeze-dried orally disintegrating tablets, and Erlotinib. They are publicly listed in China.

Bend Bioscience Inc.

United States

Bend Bioscience (formed from CoreRx, Societal CDMO, and other specialist CDMOs) is a U.S.-based small molecule pharmaceutical CDMO offering end-to-end development and manufacturing from pre-clinical to commercial scale. They specialize in oral bioavailability enhancement via spray dried dispersions, particle engineering, multiparticulates, and modified release technologies. They operate FDA, EMA, ANVISA, and DEA-inspected facilities across three U.S. locations (Oregon, Georgia, Florida) with capabilities spanning oral solids, liquids, topicals, and powders for inhalation.

Benuvia Operations, LLC

United States

Benuvia Operations, LLC is a US-based specialized CDMO and API supplier focused on controlled substances. They pioneer work with cannabinoids, psychedelics, and traditional pharmaceuticals, offering a unified services platform from IND-enabling through commercial manufacturing. They hold DEA registrations and are FDA-registered for API manufacture, analysis, labeling, manufacturing, and packing. Their SYNDROS (Dronabinol) CII product demonstrates their controlled substance expertise.

Bilim Pharmaceuticals

Turkey

Bilim Pharmaceuticals is a major Turkish pharmaceutical company with comprehensive manufacturing capabilities across three production facilities in Gebze and Cerkezkoy. Provides contract manufacturing services alongside its own branded portfolio. Facilities produce a wide range of dosage forms including solid oral doses, liquids, semi-solids, sterile injectables, and inhalation products. Subject to international regulatory inspections and has clinical trials experience.

BioDuro (BioDuro-Sundia)

China

BioDuro-Sundia is a global CRDMO (Contract Research, Development and Manufacturing Organization) offering end-to-end integrated drug discovery and development services. The company provides comprehensive chemistry services (medicinal, peptide, synthetic, analytical, scale-up), biology/DMPK, drug substance process R&D and manufacturing, drug product formulation and manufacturing, and biologics services. Has acquired a US-based Phase III/commercial drug product manufacturing facility.

BIOFAC A/S (BIOFAC Group)

Denmark

BIOFAC A/S is a Danish pharmaceutical company with 75 years of expertise, specializing in the production and supply of APIs and finished dosage forms. Key products include Lactulose (GMP-manufactured API and OEM finished products, compliant with EP and USP), heparin, chondroitin sulfate, and other bioactive ingredients from natural sources. FDA-registered with 5 inspections (1 NAI, 4 VAI). Operates through subsidiary Danipharm A/S for pharmaceutical manufacturing.

Biolab (Thailand) – Biolab Company Limited

Thailand

Biolab Company Limited is a leading Thai pharmaceutical manufacturer with 45+ years of experience, producing pharmaceuticals, dietary supplements, and cosmeceuticals. The company operates a 24,000 sqm factory in Samut Prakan, Thailand with OEM/ODM contract manufacturing capabilities. Certified PIC/S GMP (Singapore HSA), EU GMP, ISO/IEC 17025, Halal, and Thai FDA Quality Award. Exports to 20+ countries.

Biomatrix Healthcare Pvt. Ltd.

India

BioMatrix Healthcare Pvt. Ltd. is an Indian pharmaceutical company established in 2007, headquartered in Ahmedabad, specializing in 100% export of pharmaceutical products to 40+ countries. Their manufacturing facility is WHO-GMP, EU-GMP certified and compliant with US-FDA, UK-MHRA, and ANVISA standards, with Health Canada site approval. Capacity: 5 billion tablets, 1 billion capsules, 24 million liquids, and 18 million dry syrups per annum. 1,000+ product registrations. Expanding with a new API manufacturing facility in Vadodara.

Bioplus Life Sciences Pvt Ltd

India

Bioplus Life Sciences Pvt Ltd is an Indian integrated biopharmaceutical company and CDMO, with 78 years of history operating in 50+ countries. They specialize in contract development and manufacturing of oral dosage forms, APIs, and nutraceutical products. The company is also developing a novel ophthalmology drug (7-MX for pediatric myopia control) through their subsidiary Theialife. Listed as a small molecule API manufacturer on industry databases.

BMI Korea

South Korea

BMI Korea is a South Korean CDMO offering contract development and manufacturing services spanning small molecule APIs, oral solid dosage forms, biologics, vaccines, and mRNA products. The company provides integrated services from formulation development through commercial-scale manufacturing with cGMP-compliant facilities.

Bora Pharmaceutical

Canada

Bora Pharmaceuticals is a global CDMO headquartered in Canada with manufacturing facilities across North America and Asia. The company offers comprehensive contract development and manufacturing services for oral solid dosages, sterile injectables, topicals, and liquids, serving both clinical and commercial supply needs with FDA and EMA approved facilities.

Brawn Laboratories Ltd

India

Brawn Laboratories Ltd is an Indian pharmaceutical manufacturer and WHO GMP-certified company that manufactures finished dosage forms including tablets, capsules, liquids, dry syrups, creams, ointments, and eye/ear drops. The company offers R&D and CDMO services alongside its own branded product portfolio, with manufacturing facilities in Faridabad near New Delhi and a presence in over 60 countries.

BSP Pharmaceuticals

Italy

BSP Pharmaceuticals is an Italian CDMO specializing in cytotoxic, ADC (antibody-drug conjugate), and non-cytotoxic sterile injectable manufacturing. The company provides development, clinical, and commercial supply services including API synthesis, ADC conjugation and fill/finish, and oral solid dose manufacturing, with FDA and EMA approved facilities near Rome.

Cadila Pharmaceuticals Ltd

India

Cadila Pharmaceuticals Ltd is one of India's largest privately-held pharmaceutical companies, operating as both a branded generics company and CDMO/CMO. The company covers the entire life science value chain including R&D, API manufacturing, formulations across 45 therapeutic segments, drug discovery, and contract manufacturing services including vaccines.

Cambrex

Canada

Halo Pharmaceuticals, acquired by Cambrex in 2018 for $425 million and later sold to SK Capital Partners in 2023, is a drug product CDMO specializing in oral solids, liquids, creams, sterile and non-sterile ointments, complex formulations, pediatric indications, and controlled substances. The company operates 430,000 square feet of GMP-compliant manufacturing space across Whippany, New Jersey and Montreal, Quebec, serving over 85 clients.

CARBOGEN AMCIS

CHina

CARBOGEN AMCIS is a leading CDMO offering drug substance and drug product development and manufacturing services from early development through commercialization. Part of the Indian Dishman Carbogen Amcis group, the company has facilities in Switzerland, France, UK, Netherlands, and China, specializing in complex small molecule APIs, ADC payloads, and sterile drug products.